Skip to content

Randomised study of pessary vs standard management in women with increased chance of premature birth

Randomised study of pessary vs standard management in women with increased chance of premature birth

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN01096902
Enrollment
1180
Registered
2008-05-28
Start date
2008-04-15
Completion date
Unknown
Last updated
2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature birth in women with increased risk of premature birth Pregnancy and Childbirth Fetus and newborn affected by maternal complications of pregnancy

Interventions

Treatment with insertion of vaginal pessary vs expectant management. The vaginal pessary is inserted in those allocated to this group within 5 days after the 20-24+6 weeks scan. The pessary will be re

Sponsors

King's College Hospital NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Current inclusion criteria as of 12/08/2008: 1. Women with singleton pregnancies and with a cervical length of 25 mm or less 2. Women with twin pregnancies Previous inclusion criteria: 1. Women with twin pregnancies undergoing routine ultrasonography at 20-24+6 weeks of gestation for examination of foetal anatomy and growth 2. Both foetuses are found to be alive with no major abnormalities, severe twin to twin transfusion syndrome or severe foetal growth restriction

Exclusion criteria

Exclusion criteria: Current exclusion criteria as of 12/08/2008: 1. Major foetal abnormalities (defined as those that are lethal or require prenatal or postnatal surgery), foetal death, severe twin to twin transfusion syndrome or severe foetal growth restriction in one of the foetuses (in the case of twin pregnancy) diagnosed before randomisation 2. Painful regular uterine contractions, history of ruptured membranes, or prophylactic cerclage before randomisation 3. Patients who are unconscious, severely ill, mentally handicapped or under the age of 16 years Previous exclusion criteria: 1. Major foetal abnormalities (defined as those that are lethal or require prenatal or postnatal surgery), or death of one or both of the foetuses, severe twin to twin transfusion syndrome diagnosed before randomisation 2. Painful regular uterine contractions, history of ruptured membranes, or prophylactic cerclage before randomisation 3. Patients who are unconscious, severely ill or mentally handicapped 4. Under the age of 16 years

Design outcomes

Primary

MeasureTime frame
Spontaneous delivery before 34 weeks of gestation

Secondary

MeasureTime frame
1. Birth weight (mean, less than 2.5 kg and less than 1.5 kg) 2. Foetal or neonatal death 3. Major adverse outcomes before discharge from the hospital (intraventricular haemorrhage, respiratory distress syndrome, retinopathy of prematurity or necrotising entercolitis) 4. Need for neonatal special care (admission to a neonatal intensive care unit, ventilation, phototherapy, treatment for proven or suspected sepsis or blood transfusion). Duration of follow-up: 2 years

Countries

Brazil, Chile, Colombia, Portugal, Spain, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026